119th Congress · introduced in the Senate · May 6, 2025
Restoring Safeguards for Dangerous Abortion Drugs Act
Official title from Congress.gov
Latest action (May 6, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
No cosponsors.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
19 citations.
AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS · lobbying firm or registrant: AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Homeland Security
$2,150,000
Spent on own lobbying
S. 1631, H.R. 5061, H.R. 8610: Counter UAS-Drones; S. 2983: CISA 2025 Reauthorization; Cybersecurity Harmonization;
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS · lobbying firm or registrant: AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 27, 2026 · issue area: Homeland Security
$1,520,000
Spent on own lobbying
S. 1631, H.R. 5061, H.R. 8610: Counter UAS-Drones; S. 2983: CISA 2025 Reauthorization; Cybersecurity Harmonization;
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Pharmacy
$420,000
Spent on own lobbying
Shield Laws Chemical abortion drugs S. 1631, H. R. 5646 - Restoring Safeguards for Dangerous Abortion Drugs Act H.R. 679 - To nullify the modifications made by the Food and Drug Administration in January…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS · lobbying firm or registrant: AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted May 8, 2026 · issue area: Homeland Security
$1,160,000
Spent on own lobbying
S. 1631, H.R. 5061, H.R. 8610: Counter UAS-Drones; S. 2983: CISA 2025 Reauthorization; Cybersecurity Harmonization;
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL WOMEN'S LAW CENTER ACTION FUND · lobbying firm or registrant: NATIONAL WOMEN'S LAW CENTER ACTION FUND
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Family issues/Abortion/Adoption
$85,000
Spent on own lobbying
…H.R. 4849) (House and Senate) Advocacy for Momnibus Act (H.R. 7973) (House) Advocacy against Restoring Safeguards for Dangerous Abortion Drugs Act (H.R. 5646, S. 1631) (House and Senate) Advocacy against Pregnant Students' Rights Act (H.R.6359, S.3627) (House and Senate) Advocacy for veterans' abortion access (HJ Res 144, SJ…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Family issues/Abortion/Adoption
$380,000
Spent on own lobbying
…orced Abortion Prevention and Accountability Act; Patient Protection and Affordable Care Act; Abortion funding; IVF issues; National Defense Authorization Act; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Fo…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Pharmacy
$380,000
Spent on own lobbying
Shield Laws Chemical abortion drugs S. 1631, H. R. 5646 - Restoring Safeguards for Dangerous Abortion Drugs Act H.R. 679 - To nullify the modifications made by the Food and Drug Administration in January…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS · lobbying firm or registrant: AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Mar 2, 2026 · issue area: Homeland Security
$1,600,000
Spent on own lobbying
S. 1631, H.R. 5061, H.R. 8610: Counter UAS-Drones; S. 2983: CISA 2025 Reauthorization; Cybersecurity Harmonization;
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Family issues/Abortion/Adoption
$420,000
Spent on own lobbying
…Military Construction and Veterans Affairs, and Extensions Act; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Fo…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Pharmacy
$420,000
Spent on own lobbying
Shield Laws; Chemical abortion drugs; H.R. 5485 Second Chance at Life Act of 2025; Supreme Court Decisions; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Fo…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DOW CHEMICAL COMPANY DBA DOW · lobbying firm or registrant: THE DOW CHEMICAL COMPANY, DBA DOW
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Homeland Security
$910,000
Spent on own lobbying
…ngage on federal legislation related to Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act (awaiting re-introduction, previously S. 1631). Monitor and engage on the reauthorization of The Cybersecurity Information Sharing Act of 2015 (CISA). Monitor and engage on the reauthorization of The Chemi…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS · lobbying firm or registrant: AMERICAN FUEL & PETROCHEMICAL MANUFACTURERS
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Nov 6, 2025 · issue area: Homeland Security
$1,650,000
Spent on own lobbying
S. 1631, H.R. 5061, H.R. 8610: Counter UAS-Drones; S. 2983: CISA 2025 Reauthorization; Cybersecurity Harmonization
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DOW CHEMICAL COMPANY DBA DOW · lobbying firm or registrant: THE DOW CHEMICAL COMPANY, DBA DOW
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · amended · posted Oct 21, 2025 · issue area: Homeland Security
$1,340,000
Spent on own lobbying
…ngage on federal legislation related to Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act (awaiting re-introduction, previously S. 1631). Monitor and engage on the reauthorization of The Cybersecurity Information Sharing Act of 2015 (CISA). Monitor and engage on the reauthorization of The Chemi…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Family issues/Abortion/Adoption
$360,000
Spent on own lobbying
…by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Pharmacy
$360,000
Spent on own lobbying
…by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL RIGHT LIFE COMMITTEE · lobbying firm or registrant: NATIONAL RIGHT TO LIFE COMMITTEE
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 17, 2025 · issue area: Family issues/Abortion/Adoption
$25,433
Spent on own lobbying
Supported H.R. 1 The One Big Beautiful Bill Supported S.1631 Restoring Safeguards for Dangerous Abortion Drugs Act Supported H.R.983 - Second Chance at Life Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DOW CHEMICAL COMPANY DBA DOW · lobbying firm or registrant: THE DOW CHEMICAL COMPANY, DBA DOW
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Homeland Security
$1,600,000
Spent on own lobbying
…ngage on federal legislation related to Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act (awaiting re-introduction, previously S. 1631). Monitor and engage on the reauthorization of The Cybersecurity Information Sharing Act of 2015 (CISA). S. 1337, Cybersecurity Information Sharing Extension A…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Family issues/Abortion/Adoption
$490,000
Spent on own lobbying
…by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; S.242 Dignity for Aborted Children Act; Administration Personnel and Judicial Nominees; Presidential Adm…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Pharmacy
$490,000
Spent on own lobbying
…by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing